Instead of a generalised approach, strategies are aligned with personal traits, guiding whether a low-carbohydrate, low-fat, or Mediterranean diet may be more effective
As a triple-agonist, it acts on three hormone receptors: GLP-1, GIP, and GCG, regulating hunger and glucose levels
These modifications can represent physiological adjustments to accumulated environmental exposure, altered metabolic demands, and changes in neuroendocrine sensitivity across the lifespan (Videnovic et al., 2014)
Gastrointestinal side effects affect a substantial portion of Tirzepatide users
In a statement, Novo Nordisk said the rapprochement between the two companies is "a meaningful win for patients in the US" and will expand access to Ozempic and Wegovy, adding that the two products have been "evaluated for safety and efficacy." The company also said that it "welcomes Hims & Hers shifting their GLP-1 business model to focus on increasing access to affordable, branded FDA-approved medicines." It has also agreed to drop its lawsuit with Hims & Hers that followed the compounded oral semaglutide announcement
